About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Denver | 341 Studies

Clinical Trials Breast CancerDenver

Breast Cancer Clinical Trials in Denver

Find 341 clinical trials for breast cancer near Denver, Colorado. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Denver

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 341 trials

CompletedTucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast CancerThis is a multicenter run-in phase Ib / roll-over phase II study of triple targeted drug combination (HER2-targeted small molecule inhibitor tucatinib, CDK4/6 inhibitor…NCT03054363·Tucson, Arizona and 5 others TerminatedSafety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast CancerThis Phase I/II study is designed to assess the safety and therapeutic effect of INCB007839 in combination with trastuzumab and vinorelbine in patients with metastatic HER2+…NCT01254136·Fayetteville, Arkansas and 13 others CompletedEarly Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerRATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of…NCT01242800·Mobile, Alabama and 376 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast CancerA phase III, multicenter, randomized, open-label trial to evaluate the efficacy and safety of ribociclib with Endocrine Therapy (ET) as an adjuvant treatment in women and men with…NCT03701334·Birmingham, Alabama and 386 others

Active not recruitingAdditional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal TherapyThis phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take…NCT04379570·Birmingham, Alabama and 525 others

CompletedA Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerThis randomized, double-blind, placebo-controlled, two-arm study will assess the safety and efficacy of pertuzumab in addition to chemotherapy plus trastuzumab as adjuvant therapy…NCT01358877·Scottsdale, Arizona and 545 others

CompletedPaclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerThe purpose of this study is to determine the efficacy and safety of an oral dual tyrosine kinase inhibitor (GW572016) in combination with paclitaxel compared to paclitaxel alone…NCT00075270·Tucson, Arizona and 176 others

Active not recruitingExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticThis randomized phase III trial studies exemestane and entinostat to see how well they work compared to exemestane alone in treating patients with hormone receptor-positive breast…NCT02115282·Birmingham, Alabama and 652 others

CompletedALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DThis was a four-arm (parallel group) randomized, open-label, multicenter Phase 3 study to investigate the use of a combination of Lapatinib and Trastuzumab, a sequence of…NCT00490139·Mobile, Alabama and 923 others

RecruitingPalazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerThis phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic…NCT07085767·Hot Springs, Arkansas and 199 others

CompletedLapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.This study will examine safety and efficacy of Lapatinib in combination with a standard neoadjuvant chemotherapy including 5FU, Epirubicin, Cyclophosphamide and Paclitaxel.NCT00524303·Fountain Valley, California and 22 others

Active not recruitingDigital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast CancerThis randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer.NCT03233191·Birmingham, Alabama and 148 others

CompletedStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesThis is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.NCT00940225·Scottsdale, Arizona and 46 others

TerminatedA Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast CancerThis clinical trial is evaluating a drug called AC682 in participants with estrogen receptor positive/human epidermal growth factor 2 negative (ER+/HER2-) locally advanced or…NCT05080842·Denver, Colorado and 4 others

TerminatedTrilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast CancerThis was a Phase 2, multicenter, open-label, single-arm study evaluating the safety and efficacy of trilaciclib administered prior to sacituzumab govitecan-hziy in participants…NCT05113966·Chandler, Arizona and 21 others

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

CompletedNBRST: Prospective Neo-adjuvant REGISTRY TrialThe scope of this registry study is to measure chemosensitivity as defined by pCR (primary endpoint), or endocrine sensitivity as defined by partial response (decrease in longest…NCT01479101·Glendale, Arizona and 75 others

Active not recruitingAbbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense BreastsThis randomized phase II trial studies how well abbreviated breast magnetic resonance imaging (MRI) and digital tomosynthesis mammography work in detecting cancer in women with…NCT02933489·Gilbert, Arizona and 67 others

RecruitingA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in…NCT06312176·Chandler, Arizona and 258 others

UnknownChemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By SurgeryRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00408408·Little Rock, Arkansas and 441 others

Page 1 of 18Next

Other Conditions in Denver

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma